Core Insights - Peninsula Medical is experiencing rapid growth in user trust, with over 1 user receiving anti-aging or skin rejuvenation treatments every minute, and its core products have treated over 4 million users [1] - The company launched two new products, "Peninsula Big Ultrasound" and "Peninsula Counterclockwise," both of which received the highest medical device certification in China [1] - The market for anti-aging treatments in China is rapidly expanding, with 99.7% of consumers considering anti-aging important, creating significant demand for Peninsula's new products [2] Product Performance - The "Peninsula Big Ultrasound" has gained significant market attention since its NMPA III class certification, quickly becoming a trending product on social media [2] - The product's strong market performance is evidenced by high user satisfaction and repeat purchase rates, indicating its potential as a market leader [2][3] - Clinical trials for the "Peninsula Counterclockwise" show over 96% effectiveness in scar improvement and high user satisfaction rates [5][6] Technological Advancements - The "Peninsula Counterclockwise" is the first domestic product to receive both NMPA and FDA certifications, addressing key industry challenges by balancing effectiveness and comfort [4] - The "Peninsula Big Ultrasound" features advanced technology that improves energy efficiency by over 50% compared to previous models, enhancing treatment comfort and precision [5] Industry Impact - Peninsula Medical's commitment to social responsibility is highlighted by its participation in charity auctions, setting a new record in the beauty industry [3] - The company has established a strong research and development foundation, with over 1,000 patent applications and a dedicated team of nearly 400 researchers [7] - Through training programs, Peninsula Medical has certified over 12,000 professional physicians, contributing to the overall improvement of industry standards [8] Strategic Vision - Peninsula Medical aims to lead the high-end medical aesthetics market in China and globally, focusing on long-term growth and innovation [9] - The company emphasizes the integration of scientific research and clinical practice to enhance user experience and product effectiveness [9]

Core Viewpoint - The issuance of the first Class III certificate for ultrasound medical beauty equipment in China marks a significant breakthrough for Shenzhen Peninsula Medical Group, indicating the entry of domestic ultrasound medical devices into a higher compliance era [1][2][4] Industry Summary - The Chinese medical beauty industry is projected to exceed 400 billion yuan by 2025, driven by the booming "beauty economy" and the rapid expansion of the non-surgical light medical beauty market due to its low risk and quick recovery characteristics [2] - The term "ultrasound cannon" originated in Shenzhen, with Peninsula Medical's product being the first ultrasound medical device to receive NMPA certification in China [2][3] Company Summary - Peninsula Medical's ultrasound cannon series holds approximately 80% market share in its niche, with over 100,000 units sold and coverage in more than 10,000 hospitals and medical institutions globally [3] - The "Peninsula Big Ultrasound Cannon" took nearly four years to obtain the Class III certificate, involving extensive clinical trials and regulatory compliance [3][4] - The recent regulatory changes require ultrasound beauty devices to adhere to the strictest safety standards, with Class III devices needing clinical validation before market entry, establishing a "gold standard" for the industry [3][4]